Hem › Blodcancer › Illinois › Chicago
Kliniska studier för Blodcancer i Chicago, IL
15 studier för Blodcancer söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RekryterarFas 3
- The University of Chicago ( Site 0020), Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- och 1 fler
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekryterarObservationsstudie
- Swedish Covenant Hospital, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekryterarFas 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
RekryterarObservationsstudieFriska volontärer välkomna
- Tempus AI, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Rekryterar
- Northwestern University Feinberg School of Medicine, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- och 2 fler
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RekryterarFas 3
- Northwestern University, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekryterarFas 1
- University of Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekryterarFas 1/2
- Northwestern Memorial Hospital, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekryterarFas 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Rekryterar
- University of Chicago Comprehensive Cancer Center, Chicago
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
RekryterarFas 1
- Northwestern University - Feinberg School of Medicine, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RekryterarObservationsstudie
- MPN Research Foundation, Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekryterarFas 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Blodcancer-studier i andra städer
- Houston, TX46 studier
- New York City, NY26 studier
- Boston, MA25 studier
- Washington, DC19 studier
- Baltimore, MD18 studier
- Seattle, WA18 studier
- Los Angeles, CA17 studier
- Durham, NC16 studier
- Philadelphia, PA14 studier
- Atlanta, GA13 studier
- Nashville, TN13 studier
- Edison, NJ13 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer58 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Övervikt41 studier
- Lungcancer41 studier
- Äggstockscancer36 studier
- Stroke34 studier
- Kolorektal cancer33 studier
- Hjärtsvikt31 studier
- Övervikt28 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.